CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities
Net loss	$ (10,621)	$ (58,579)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,534	1,452
Equity-based compensation	5,089	4,324
Change in fair value of warrants	(3,430)	(6,041)
Debt extinguishment loss		13,734
Issuance of common warrants		5,766
Change in fair value of derivative liability	(9,175)	24,523
Realized and unrealized gain on short term investments	(960)	(338)
Equity method investment loss	67	39
Asset retirement obligation accretion	50	26
Amortization of debt discount	2,776	1,739
Changes in operating assets and liabilities:
Accounts receivable	966	1,656
Other current assets	(622)	(749)
Other assets	22	16
Accounts payable	841	273
Deferred revenue	142	22
Accrued expenses and other liabilities	3,203	(254)
Operating lease right-of-use assets and liabilities	77	212
Net cash used in operating activities	(10,041)	(12,179)
Investing activities
Purchases of network assets, property, and equipment	(10)	(30)
Purchase of internal use software	(126)	(101)
Purchase of marketable securities	(88,020)	(31,463)
Sale and maturity of marketable securities	84,000	34,600
Net cash (used in) provided by investing activities	(4,156)	3,006
Financing activities
Proceeds from 2028 senior convertible notes		190,000
Repayment of 2026 senior secured notes		(70,000)
Payments towards debt issuance cost		(550)
Payments towards debt	(30)	(27)
Proceeds from exercise of common warrants	13	517
Proceeds from exercise of common stock options	250	232
Net cash provided by financing activities	233	120,172
Effect of exchange rates on cash and cash equivalents	(195)	93
Net (decrease) increase in cash and cash equivalents	(14,159)	111,092
Cash and cash equivalents at beginning of period	44,757	39,330
Cash and cash equivalents at end of period	30,598	150,422
Supplemental disclosures
Interest paid in cash		2,256
Income taxes paid, net	$ 74	$ 64